Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines

NCT01502345 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

FED

Sponsor class

Conditions

Hemorrhagic Fever With Renal Syndrome

Interventions

BIOLOGICAL: Vaccine/device combination for prevention of HFRS

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]